Clinical, Cosmetic and Investigational Dermatology (Jul 2021)
The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments
Abstract
Izolda Heydenrych,1 Koenraad De Boulle,2 Krishan Mohan Kapoor,3 Dario Bertossi4 1Cape Town Cosmetic Dermatology Centre, Century City, Cape Town, South Africa; 2Aalst Dermatology Clinic, Aalst, Belgium; 3Department of Plastic Surgery, Fortis Hospital, Mohali, India; 4Maxillofacial Department, University of Verona, Verona, ItalyCorrespondence: Izolda HeydenrychCape Town Cosmetic Dermatology Centre, Central Park on Esplanade, Postnet Suite 136, Century City, Cape Town, 7442, South AfricaTel +27 21 552 7220Fax +27 21 552 7229Email [email protected]: Dermal filler treatments require constant reassessment for improving and safeguarding the rapidly evolving aesthetic field. Suboptimal injection technique, patient selection and product knowledge have touted a concerning increase in filler complications, with new challenges such as the COVID-19 pandemic leading to new paradigms in the understanding, prevention, diagnosis and treatment of complications. The updated 10-point plan has been developed to curtail complications through consideration of causative factors, categorized as patient, product, and procedure-related. Patient-related factors include a preprocedural consultation with careful elucidation of skin conditions (acne, rosacea, dermatitis), systemic disease (allergies, autoimmune disease, underlying bacterial and viral disease (herpes simplex virus, COVID-19 infection), medications (antineoplastic drugs, recreational drugs) and previous cosmetic procedures (including fillers and energy-based devices). Patient assessment should include standardized photography and also evaluate the role of social media, ethnicity, gender, generational, and LGBTQ+ needs. Specified informed consent for both adverse events and their treatment is essential due to the increase in vascular complications, including the risk of blindness. Product-related factors include the powerful advantage of reversibility when using hyaluronic acid (HA) products. Product characteristics such as molecular weight and filler degradation should be understood. Product layering over late or minimally degradable fillers is still inadvisable due to the initial filler being teased into reactivity. Procedural factors such as consistent photographic documentation, procedural planning, aseptic non-touch technique (ANTT), knowledge of topographical anatomy and angiosomes, and technical dexterity including pinch anatomy and needle skills are of pivotal importance. The final section is dedicated to algorithms and checklists for managing and treating complications such as allergic hypersensitivity reactions, vascular events, infection, edema and late-onset adverse events (LOAEs). The updated 10-point plan is a methodical strategy aimed at further minimising the risk of dermal filler complications.Keywords: assessment, complications, dermal fillers, prevention, treatment
